Last reviewed · How we verify
NCT05039034: SAMHPSDC
Screening and Management of High-risk Populations of Stroke in Dehui City
trial testing Advice according to primary prevention guidelines on stroke of China in Cerebrovascular Accident in 4,100 participants. Completed in 31 March 2017.
31 March 2016
Quick facts
| Lead sponsor | Yi Yang |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 4,100 |
| Start date | 1 January 2016 |
| Primary completion | 31 March 2016 |
| Estimated completion | 31 March 2017 |
| Sites | 1 location across China |
Drugs / interventions tested
- Advice according to primary prevention guidelines on stroke of China
Conditions studied
- Cerebrovascular Accident — all drugs for Cerebrovascular Accident →
- Stroke — all drugs for Stroke →
- Hypertension — all drugs for Hypertension →
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
Yi Yang — full company profile →
Who can join
40 and older, any sex, with Cerebrovascular Accident or Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This epidemiological survey is to analyze the prevalence rate of stroke and exposure rate of risk factors in sampling population aged 40 years and over (born before December 31,1975) in Dehui City, to provide scientific basis for pertinent prevention and control of stroke in Jilin Province, and to provide valuable data for the high-risk groups to carry out regular follow-up and standardized management.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05039034
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cerebrovascular Accident
Currently open trials in the same condition.
- NCT07272239 — Effects of tVNS and mCIMT in Chronic Stroke · NA · recruiting
- NCT06498011 — COgnitive-somatoSensory-MOtor Training to Improve Arm and Hand Function After Stroke (iCOSMO) · NA · recruiting
- NCT06521801 — Cardio-Renal Registry · recruiting
- NCT06371937 — iPSC Biobank of Biomarkers Diversity in Cardiovascular Disease · recruiting
- NCT06107010 — Effects of Atalante Exoskeleton on Gait Recovery in Non- or Poorly Ambulatory Patients With Hemiparesis in the Acute/Sub · NA · recruiting
Other Yi Yang trials
Trials by the same sponsor.
- NCT03484936 — Safety and Efficacy of Remote Ischemic Conditioning in Patients With Spontaneous Intracerebral Hemorrhage · NA · not yet recruiting
- NCT07042490 — Efficacy and Safety of Plasma Adsorption Combined With EVT for AIS-LVO · NA · not yet recruiting
- NCT03669653 — Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Ischemic Stroke · NA · not yet recruiting
- NCT05743101 — Safety and Efficacy Study of Levofloxacin Combined With Endovascular Thrombectomy for Acute Ischemic Stroke · NA · not yet recruiting
- NCT06941961 — iTBS for Acute Ischemic Stroke After Thrombectomy · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05039034 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yi Yang
- Last refreshed: 9 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05039034.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing